4 ms·
I will say that on the vaccine front the data provided by Israel seems to be the worst results of the bunch, and while we can't completely rule out their result
by colincooke 5y ago
I will say that on the vaccine front the data provided by Israel seems to be the worst results of the bunch, and while we can't completely rule out their results there is a good chance it's an underestimate of efficacy. Here are some efficacy estimates against Delta from other sources:
https://twitter.com/EricTopol/status/1414254993536786433 https://twitter.com/EricTopol/status/1414254993536786433
Highlights are (symtoms/hospitilization):
- Phizer: 79-88%/96%
- Moderna (one dose, not much data): 72%/96%
- Astra: 60-67%/92%
- Unklejoe 5y agoAre you aware of any results for the J&J shot? That's the one I got but it always seems to be left out.
- selectodude 5y agoHere you go, straight from the horses mouth. Take that as you will. "A preprint submitted by the Company today to bioRxiv contains a new analysis from blood samples obtained from a subset of participants (n=8) in the Phase 3 ENSEMBLE study. These data showed that the Johnson & Johnson single-shot COVID-19 vaccine elicited neutralizing antibody activity against the Delta variant at an even higher level than what was recently observed for the Beta (B.1.351) variant in South Africa where high efficacy against severe/critical disease was demonstrated." https://www.jnj.com/positive-new-data-for-johnson-johnson-single-shot-covid-19-vaccine-on-activity-against-delta-variant-and-long-lasting-durability-of-response https://www.jnj.com/positive-new-data-for-johnson-johnson-si...
- AnimalMuppet 5y agon=8?!? That's... um... nice for those eight people, I guess. It's sure not much to draw conclusions from, though. (I also got J&J, so I hope they're right. But the sample size makes this little better than anecdote.)
- 015a 5y agoAin't that the truth. I opted for the J&J almost solely because the media & government strongly suggested it would be the "primary" vaccine going forward; given it only required one dose, scale-up would be easier, easier to transport, more people would end up with it, and thus I figure it would receive the largest scientific scrutiny for positive and negative side-effects going forward. Far from it. Those of us who got it now feel like the weird step-children of the COVID pandemic, constantly left out of headlines and media. Though, I guess at least, it can very rarely cause an extremely dangerous nerve condition, so we got that going for us which is nice.